Lichen planus after SARS-CoV-2 infection treated with lopinavir/ritonavir

Med Clin (Barc). 2021 May 7;156(9):468-469. doi: 10.1016/j.medcli.2020.12.014. Epub 2021 Jan 28.
[Article in English, Spanish]
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / therapeutic use
  • COVID-19 Drug Treatment*
  • Drug Combinations
  • Humans
  • Lichen Planus* / drug therapy
  • Lopinavir / adverse effects
  • Ritonavir / adverse effects
  • SARS-CoV-2

Substances

  • Antiviral Agents
  • Drug Combinations
  • Lopinavir
  • Ritonavir